We are focusing on endoscopic intervention therapy market and prioritize the development of single-use electronic endoscope product.
Engineering the extraodinary
Groundbreaking healthcare technology solutions for the most complex and challenging conditions. Inspiring hope and new possibility in people all over the world.
MacroLux Medical Technology Co., Ltd. announced the successful close of its Series B+ financing round led by B Capital. The funding will support MacroLux Medical’s continued global expansion and accelerate growth in the disposable endoscope market.
From November 11 to 14, 2024, MacroLux Medical participated in Medica 2024 at the Düsseldorf Exhibition Center in Germany. This event is a significant occasion in the global medical technology field, attracting top medical technology and innovative achievements from around the world.
We are very pleased to announce that our company (hereinafter referred to as MacroLux Medical) recently announced the completion of over 14 million dollars in Series B financing. The round was led by Yuanbio Venture Capital, with continued support from existing shareholders Legend Capital and Dalton Venture, and Haoyue Capital acted as the exclusive financial advisor.
Congratulations to MacroLux Medical on obtaining CE-MDR certification for their three cutting-edge disposable digital endoscopes: LoopView® Single-Use Digital Flexible Bronchoscope, BubbleView® Single-Use Digital Flexible Cystoscope, and SeleneView® Single-Use Digital Hysteroscope.
From August 12th to 16th, 2024, the 41st World Congress of Endourology and Uro-Technology (WCET) was held in Seoul, South Korea. MacroLux Medical showcased its superior urological products during the event in Seoul.
We are thrilled to announce that our disposable hysteroscope SeleneView® has obtained the 510(k) clearance from the U.S. Food and Drug Administration (FDA), marking a momentous milestone for us.
BAUS2024, organized by the British Association of Urological Surgeons (BAUS), brings together urological experts, scholars, and practitioners from around the world. This conference aims to drive innovation and advancement in the field of urology, providing a platform to exchange the latest research findings, clinical practices, and technological developments.
MacroLux is proud to introduce urologists to their innovative single-use cystoscope, offering a seamless workflow and potential productivity advantages. The BubbleViewTM Single-Use Digital Flexible Cystoscope received 510(k) clearance from the U.S. Food and Drug Administration on June 10, 2024, and is now ready for launch in North America.
The American College of Obstetricians and Gynecologists (ACOG 2024) Clinical and Scientific Meeting (ACSM 2024) took place from May 17th to 19th, 2024, in San Francisco, California, USA.
